HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ghassan Shattat Selected Research

tyloxapol

8/2013The pharmacological effects of novel 5-fluoro-N-(9,10-dihydro-9,10-dioxoanthracen-8-yl)-1H-indole-2-carboxamide derivatives on plasma lipid profile of Triton-WR-1339-induced Wistar rats.
9/2011Antihyperlipidemic properties of novel N-(benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-induced hyperlipidemic rats.
9/2009Pharmacological evaluation of novel indole-2-carboxamides as potent lipid-lowering agents in Triton-WR-1339-induced hyperlipidemic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ghassan Shattat Research Topics

Disease

5Hyperlipidemias (Hyperlipidemia)
07/2017 - 09/2009
4Body Weight (Weight, Body)
09/2011 - 09/2009
1Type 2 Diabetes Mellitus (MODY)
09/2012

Drug/Important Bio-Agent (IBA)

4Triglycerides (Triacylglycerol)IBA
09/2011 - 09/2009
3BezafibrateIBA
07/2017 - 05/2010
3tyloxapolFDA Link
08/2013 - 09/2009
3LipidsIBA
09/2012 - 09/2009
1CholesterolIBA
07/2017
1Fatty Acids (Saturated Fatty Acids)IBA
07/2017
1Lipoproteins (Lipoprotein)IBA
07/2017
1Hemoglobins (Hemoglobin)IBA
09/2012
1N- (benzoylphenyl)- 5- fluoro- 1H- indole- 2- carboxamideIBA
08/2010
1indoleIBA
09/2009
1Hypolipidemic Agents (Antihyperlipidemics)IBA
09/2009

Therapy/Procedure

3Intraperitoneal Injections
08/2013 - 09/2009
1Glycemic Control
09/2012